NasdaqCM - Nasdaq Real Time Price USD

Cidara Therapeutics, Inc. (CDTX)

18.63
-0.52
(-2.72%)
At close: May 9 at 4:00:01 PM EDT
18.63
0.00
(0.00%)
After hours: May 9 at 4:05:10 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,275
1,275
23,283
64,448
49,572
Cost of Revenue
--
--
1,523
0
--
Gross Profit
--
--
62,382
64,448
--
Operating Expense
177,377
177,377
50,343
97,951
91,827
Operating Income
-176,102
-176,102
-27,060
-33,503
-42,255
Net Non Operating Interest Income Expense
5,811
5,811
1,995
191
-212
Pretax Income
-170,291
-170,291
-25,065
-33,312
-42,467
Tax Provision
0
0
15
272
0
Net Income Common Stockholders
-169,827
-169,827
-22,931
-33,584
-42,467
Diluted NI Available to Com Stockholders
-169,827
-169,827
-22,931
-33,584
-42,467
Basic EPS
-26.75
-26.75
-5.25
-8.60
-16.20
Diluted EPS
-26.75
-26.75
-5.25
-8.60
-16.20
Basic Average Shares
6,349.63
6,349.63
4,371.38
3,492.88
2,622.67
Diluted Average Shares
6,349.63
6,349.63
4,371.38
3,492.88
2,622.67
Total Operating Income as Reported
-176,102
-176,102
-27,060
-33,503
-42,255
Total Expenses
177,377
177,377
50,343
97,951
91,827
Net Income from Continuing & Discontinued Operation
-169,827
-169,827
-22,931
-33,584
-42,467
Normalized Income
-170,291
-170,291
-25,080
-33,584
-42,467
Interest Income
5,811
5,811
1,995
191
--
Net Interest Income
5,811
5,811
1,995
191
-212
EBIT
-176,102
-176,102
-27,060
-33,503
-42,255
EBITDA
-175,869
-175,869
-26,942
-33,360
-42,255
Reconciled Cost of Revenue
--
--
1,523
0
--
Reconciled Depreciation
233
233
118
143
-1,230
Net Income from Continuing Operation Net Minority Interest
-170,291
-170,291
-25,080
-33,584
-42,467
Normalized EBITDA
-175,869
-175,869
-26,942
-33,360
-42,255
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/15/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GLYC GlycoMimetics, Inc.
0.2402
-0.95%
 
OLMA Olema Pharmaceuticals, Inc.
4.6000
-1.50%
 
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
 
NUVL Nuvalent, Inc.
69.85
-2.44%
 
ETNB 89bio, Inc.
7.70
-1.16%
 
RZLT Rezolute, Inc.
3.7000
-0.54%
 
DBVT DBV Technologies S.A.
9.83
-0.10%
 
SYRE Spyre Therapeutics, Inc.
14.10
+9.64%
 
CLDX Celldex Therapeutics, Inc.
18.33
-6.10%
 
PEPG PepGen Inc.
1.5000
-2.60%